Analysts’ View: Sun Life (SLF), Deciphera Pharmaceuticals (DCPH), iStar (STAR)

Investment Analysts Argus upgrade Sun Life Financial Inc. (NYSE:SLF) shares from Hold to Buy rating.

Sun Life Financial Inc., a financial services company, provides insurance, wealth, and asset management solutions to individuals and corporate clients, high-net-worth individuals, and families.


Brokerage Firm B. Riley FBR upgraded Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) shares from Neutral to Buy rating while increasing thier price target from $27 to $34.

Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of various cancer therapies.


iStar, Inc. (NYSE:STAR) shares were upgraded by analysts at JMP Securities from Market Perform to Market Outperform rating.

iStar finances, invests in and develops real estate and real estate related projects as part of its fully-integrated investment platform.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at